Synopsis : This marks the second indication for Pemazyre, which received accelerated FDA approval in 2020 for adults with previously treated, unresectable…
Summary : OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE), today announced that early biomarker analyses from the ongoing Phase 1 clinical trial with SIRPα…
Summary : Pfizer Inc. (plaintiff) filed a patent infringement suit against West-Coast Pharmaceutical works Ltd. (defendant) for inviting manufacturers to contract with…
Summary : The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy…
Summary : Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria In this Phase 3 trial, Dupixent…
Summary : Collaboration offers clinicians access to a state-of-the-art, cloud based oncology decision support platform that fully integrates the latest codified clinical…
Summary : Moderna is poised to begin Phase III of its pivotal clinical trial for its candidate vaccine for respiratory syncytial virus…
Synopsis : ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global,…
Summary : At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business,…
Summary : Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes National Institute for Health…